Expression of vitamin D receptor decreases during progression of pigmented skin lesions
- 1 May 2011
- journal article
- Published by Elsevier BV in Human Pathology
- Vol. 42 (5), 618-631
- https://doi.org/10.1016/j.humpath.2010.09.014
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health
This publication has 48 references indexed in Scilit:
- Vitamin D: newly discovered actions require reconsideration of physiologic requirementsTrends in Endocrinology & Metabolism, 2010
- 20,23‐dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF‐κB activity in human keratinocytesJournal of Cellular Physiology, 2009
- Neuroendocrine activity of the melanocyteExperimental Dermatology, 2009
- Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case–control comparisons and a meta-analysis of published VDR dataEuropean Journal Of Cancer, 2009
- Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysisJNCI Journal of the National Cancer Institute, 2009
- Photo-conversion of two epimers (20R and 20S) of pregna-5,7-diene-3β, 17α, 20-triol and their bioactivity in melanoma cellsSteroids, 2008
- Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cellsInternational Journal of Cancer, 2008
- 20-Hydroxyvitamin D3, a Product of Vitamin D3 Hydroxylation by Cytochrome P450scc, Stimulates Keratinocyte DifferentiationJournal of Investigative Dermatology, 2008
- Vitamin D Receptor Expression in Normal, Premalignant, and Malignant Human Lung TissueCancer Epidemiology, Biomarkers & Prevention, 2008
- The Hallmarks of CancerCell, 2000